Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00472654 · ClinicalTrials.gov registry record · NA
The Effect of Vitamin D Supplementation During Caloric Restriction on Intestinal Calcium Absorption
A NA study, sponsored by Rutgers University.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT00472654: Completed NA study, sponsored by Rutgers University.
NCT00472654 is a NA study that has completed, run by Rutgers University. The registered enrollment target is 83 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00472654, a NA study, has completed, sponsored by Rutgers University.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
The purpose of this study is to learn how the amount of vitamin D supplementation influences intestinal fractional calcium absorption (a measure of the amount of calcium absorbed).
Interventions
- BEHAVIORAL Weight Loss
- BEHAVIORAL Weight Maintenance
- DIETARY_SUPPLEMENT Vitamin D 2500 IU
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-03 |
| Phase | NA |
What the finished NCT00472654 record still lists
NCT00472654 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Weight Loss is the first listed.
NCT00472654 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00472654 about?
NCT00472654 is a clinical study titled "The Effect of Vitamin D Supplementation During Caloric Restriction on Intestinal Calcium Absorption". The purpose of this study is to learn how the amount of vitamin D supplementation influences intestinal fractional calcium absorption (a measure of the amount of calcium absorbed).
What is the current status of trial NCT00472654?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2007-03. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00472654?
The interventions under investigation include: Weight Loss (BEHAVIORAL), Weight Maintenance (BEHAVIORAL), Vitamin D 2500 IU (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00472654?
This trial is sponsored by Rutgers University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00472654's enrollment target sits among peer trials
83 990th of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia